PubRank

David L Van Brunt

Author PubWeight™ 16.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend 2006 1.98
2 Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. Int J Methods Psychiatr Res 2007 1.87
3 Weight management using the internet a randomized controlled trial. Am J Prev Med 2008 1.76
4 Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale. Arch Gen Psychiatry 2010 1.68
5 The nonmedical use of prescription ADHD medications: results from a national Internet panel. Subst Abuse Treat Prev Policy 2007 1.64
6 Associations of nonrestorative sleep with insomnia, depression, and daytime function. Sleep Med 2010 1.48
7 Stimulant formulation and motivation for nonmedical use of prescription attention-deficit/hyperactivity disorder medications in a college-aged population. Am J Addict 2010 0.93
8 Prevalence of nonmedical methamphetamine use in the United States. Subst Abuse Treat Prev Policy 2008 0.91
9 The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone. J Clin Psychiatry 2006 0.90
10 A retrospective claims analysis of combination therapy in the treatment of adult attention-deficit/hyperactivity disorder (ADHD). BMC Health Serv Res 2009 0.88
11 Test-retest reliability of two patient-report measures for use in adults with ADHD. J Atten Disord 2010 0.85
12 Improvements in access to care for HIV and AIDS in a statewide Medicaid managed care system. Am J Manag Care 2003 0.82
13 Impact of a statewide Medicaid managed care system on healthcare utilization and outcomes for people living with HIV. Am J Med Sci 2004 0.78
14 Decreased use of clonidine following treatment with atomoxetine in children with ADHD. J Clin Psychopharmacol 2006 0.76
15 Medication costs to private insurers of diversion of medications for attention-deficit hyperactivity disorder. Pharmacoeconomics 2011 0.75